Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of thalidomide in treating patients who have
recurrent or persistent endometrial cancer. Thalidomide may stop the growth of cancer by
stopping blood flow to the tumor